SNOA - Sonoma Pharmaceuticals, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

SNOA

SONOMA PHARMACEUTICALS, INC.

NASDAQ

$1.32

▲ UP 0.38% (0.01)

KEY STATISTICS

Market Cap$2.23 M

52w High$4.70

52w Low$0.85

Dividend Yield—

Frequency—

P/E-1.12

Volume92.79K

Shares Out.1.68M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Amy Trombly

COMPENSATION 2026

Salary$407,500

Stock Awards$74,875

Incentive Plan Pay$0

All Other Comp.$63,741

Total$741,116

ABOUT

SECTOR

Healthcare

WENT PUBLIC

January 25, 2007

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

UPCOMING EARNINGS

DateNov 16, 2026

DayMonday

Rev. Est.$5.29M

NOV

MON

SPLIT RECORD

DATE	TYPE	RATIO
2024-08-30	Reverse	1:20
2019-06-20	Reverse	1:9
2016-06-27	Reverse	1:5
2013-04-01	Reverse	1:7

PRICE

$1.32 ▲ UP 0.38% (+$0.01)

OVERLAYS

About Sonoma Pharmaceuticals, Inc.

https://www.sonomapharma.com ↗

Sonoma Pharmaceuticals develops and manufactures HOCl-based products for wound, skin, animal, eye, and oral care globally, including antimicrobial cleansers, topical treatments, and disinfectants.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT SONOMA PHARMACEUTICALS, INC. IS KNOWN FOR

HOCl-based diaper rash hydrogel

Sonoma Pharmaceuticals' OTC antimicrobial hydrogel, treating diaper rash and skin irritations for infants and children, launched in 3,600 Walmart stores, marking a major expansion into the consumer market.

COMPETITORS

COMPETITOR

Revenue by Products

Icon	PRODUCT	Q2-2026	Q3-2026	Q4-2026	Q1-2027
	Human Care	$5.12M	$3.86M ▼	$8.7M ▲	$5.97M ▼
	Animal Care	$488K	$486K ▼	$874K ▲	$439K ▼

Revenue by Geography

REGION	Q3-2020	Q1-2021	Q2-2021	Q3-2021
UNITED STATES	$2.06M	$1.72M ▼	$1.98M ▲	$1.98M ▼
Europe and Rest of the World	$1.33M	$3.21M ▲	$1.76M ▼	$1.65M ▼
Latin America	$988K	$2.32M ▲	$2.02M ▼	$1.31M ▼